The Human Amylin Analog, Pramlintide, Reduces Postprandial Hyperglucagonemia in Patients with Type 2 Diabetes Mellitus
- 1 September 2002
- journal article
- clinical trial
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 34 (9), 504-508
- https://doi.org/10.1055/s-2002-34790